<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Orexigen Therapeutics]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Orexigen Therapeutics on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=585418"/>
<item>
<title><![CDATA[Vivus's Free Promotion Lifts Prescriptions for Diet Drug]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/07/vivus-free-promotion-lifts-prescriptions-for-diet-drug/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/07/vivus-free-promotion-lifts-prescriptions-for-diet-drug/</guid>
<pubDate><![CDATA[Mon, 07 Jan 2013 10:58:49 EST]]></pubDate>
<description><![CDATA[Vivus Inc. (VVUS) reported a 67% increase in prescriptions for the weight-loss drug Qsymia, helped by a promotion that began in November to give patients the first two weeks of their prescriptions for free.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Amicus Therapeutics, Its CEO Await Key Data on Rare-Disease Drugs]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/11/08/amicus-therapeutics-its-ceo-await-key-data-on-rare-disease-drugs/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/11/08/amicus-therapeutics-its-ceo-await-key-data-on-rare-disease-drugs/</guid>
<pubDate><![CDATA[Thu, 08 Nov 2012 13:08:23 EST]]></pubDate>
<description><![CDATA[John Crowley rose to fame in the early 2000s as a Genzyme Corp. executive who helped develop a treatment for a fatal rare disease affecting his two young children.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Vivus, Orexigen Climb Ahead Of FDA Decision]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/07/16/vivus-orexigen-climb-ahead-fda-decision/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/07/16/vivus-orexigen-climb-ahead-fda-decision/</guid>
<pubDate><![CDATA[Mon, 16 Jul 2012 13:20:00 EDT]]></pubDate>
<description><![CDATA[Shares of Vivus Inc. jumped 5% to $28.63 Monday in anticipation that the U.S. Food and Drug Administration will soon approve its diet drug Qnexa.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Community Health Systems, Orexigen Therapeutics Among Stocks Setting 52-Week Highs Thursday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/06/28/community-health-systems-orexigen-therapeutics-among-stocks-setting-52-week/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/06/28/community-health-systems-orexigen-therapeutics-among-stocks-setting-52-week/</guid>
<pubDate><![CDATA[Thu, 28 Jun 2012 12:32:35 EDT]]></pubDate>
<description><![CDATA[These nine stocks hit 52-week highs: While trading on above-average volume, Community Health Systems (NYSE:CYH) climbed today, reaching and then surpassing its previous 52-week high of $27.63.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Orexigen Therapeutics, Flow International Corporation Gapping Up Thursday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/06/28/orexigen-therapeutics-flow-international-corporation-gapping-up-thursday/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/06/28/orexigen-therapeutics-flow-international-corporation-gapping-up-thursday/</guid>
<pubDate><![CDATA[Thu, 28 Jun 2012 10:31:20 EDT]]></pubDate>
<description><![CDATA[These stocks gapped up today and had open prices sharply higher than the previous trading day's close: Orexigen Therapeutics (NASDAQ:OREX) closed the previous trading session at $4.92, gapping up to open at $5.53 today.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA OKs Arena Obesity Drug; First in 13 Years]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2012/06/27/fda-oks-arena-obesity-drug-first-in-13-years/?]]></link>
<guid>http://www.foxbusiness.com/industries/2012/06/27/fda-oks-arena-obesity-drug-first-in-13-years/</guid>
<pubDate><![CDATA[Wed, 27 Jun 2012 13:36:58 EDT]]></pubDate>
<description><![CDATA[U.S. health regulators approved Arena Pharmaceuticals' pill to treat obesity, making it the first new weight-loss drug in 13 years.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Arena Pharmaceuticals, Dendreon Corporation Among Stocks Up on High Volume Wednesday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/06/13/arena-pharmaceuticals-dendreon-corporation-among-stocks-up-on-high-volume/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/06/13/arena-pharmaceuticals-dendreon-corporation-among-stocks-up-on-high-volume/</guid>
<pubDate><![CDATA[Wed, 13 Jun 2012 12:33:29 EDT]]></pubDate>
<description><![CDATA[Here are stocks that are up on high volume: Trading with a volume of 38.2 million, or 2.4 times its average daily volume, Arena Pharmaceuticals (NASDAQ:ARNA) is up on high volume today.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Health Care Sector Wrap]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/05/11/health-care-sector-wrap/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/05/11/health-care-sector-wrap/</guid>
<pubDate><![CDATA[Fri, 11 May 2012 16:39:58 EDT]]></pubDate>
<description><![CDATA[During trading today, the Health Care sector (XLV) showed little change while the S&P 500 fell 0.3%.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA Weighs Heart Trials for Obesity Drugs]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2012/03/26/fda-weighs-heart-trials-for-obesity-drugs/?]]></link>
<guid>http://www.foxbusiness.com/industries/2012/03/26/fda-weighs-heart-trials-for-obesity-drugs/</guid>
<pubDate><![CDATA[Mon, 26 Mar 2012 13:25:41 EDT]]></pubDate>
<description><![CDATA[Health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/investing/fdaBuilding.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Vivus Rockets 99% On FDA Nod]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/02/23/vivus-rockets-on-fda-nod/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/02/23/vivus-rockets-on-fda-nod/</guid>
<pubDate><![CDATA[Thu, 23 Feb 2012 09:51:00 EST]]></pubDate>
<description><![CDATA[Shares of Vivus Inc. rocketed 99% to $20.95 early Thursday, the day after an advisory panel of the U.S. Food and Drug Administration voted to recommend the agency approve Vivus's diet drug Qnexa.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA Official Sees Drug Approvals Rising]]></title>
<link><![CDATA[http://www.foxbusiness.com/personal-finance/2011/05/10/fda-official-sees-drug-approvals-rising/?]]></link>
<guid>http://www.foxbusiness.com/personal-finance/2011/05/10/fda-official-sees-drug-approvals-rising/</guid>
<pubDate><![CDATA[Wed, 11 May 2011 09:36:22 EDT]]></pubDate>
<description><![CDATA[A top agency official said the FDA is seeing a rising number of new drugs ready for approval and expects a gradual increase in medicines that reach the market.]]></description>
<media:thumbnail>http://www.foxbusiness.com/static/managed/img/medicine_pills_health_care.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Back-to-School Hits the Road]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/932736959001/back-to-school-hits-the-road-/?]]></link>
<guid>http://video.foxbusiness.com/v/932736959001/back-to-school-hits-the-road-/</guid>
<pubDate><![CDATA[Thu, 05 May 2011 16:09:56 EDT]]></pubDate>
<description><![CDATA[We break down what consumers are expecting from back-to-school sales, and what will keep you going the rest of the summer.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/073010/640/360/073010_fbl_fullshow_FBN_073010_13-21.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[The Skinny on Diet Pills]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/931722088001/the-skinny-on-diet-pills-/?]]></link>
<guid>http://video.foxbusiness.com/v/931722088001/the-skinny-on-diet-pills-/</guid>
<pubDate><![CDATA[Thu, 05 May 2011 08:06:04 EDT]]></pubDate>
<description><![CDATA[FOXNewshealth.com Managing Editor Dr. Manny Alvarez on the new diet pill Contrave, backed by the FDA.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/120810/100/75/120810_fb_manny_FBN_120810_11-49.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Blue Chips Blow Past 12000 in Bullish February Debut]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2011/01/31/futures-float-higher-february-debut/?]]></link>
<guid>http://www.foxbusiness.com/markets/2011/01/31/futures-float-higher-february-debut/</guid>
<pubDate><![CDATA[Tue, 01 Feb 2011 16:14:21 EST]]></pubDate>
<description><![CDATA[Wall Street flipped the calendar to February with bullish enthusiasm on Tuesday as the Dow surged beyond 12000 and the S&P 500 conquered 1300 for the first time in two-and-a-half years amid enthusiasm for impressive manufacturing and earnings reports from around the world.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/New-York-Stock-Exchange-Building-Looking-Up12.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Orexigen Shares Jump Ahead Of FDA Decision]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2011/01/31/orexigen-shares-jump-ahead-fda-decision/?]]></link>
<guid>http://www.foxbusiness.com/markets/2011/01/31/orexigen-shares-jump-ahead-fda-decision/</guid>
<pubDate><![CDATA[Mon, 31 Jan 2011 10:13:00 EST]]></pubDate>
<description><![CDATA[BOSTON -- Shares of Orexigen Therapeutics jumped 10% Monday morning. The U.S. Food and Drug Administration is expected to issue a decision by the end of Monday on whether it will approve Orexigen's diet drug Contrave.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Orexigen Obesity Drug Gains Traction Toward FDA Approval]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/12/08/orexigen-obesity-drug-gains-traction-fda-approval/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/12/08/orexigen-obesity-drug-gains-traction-fda-approval/</guid>
<pubDate><![CDATA[Wed, 08 Dec 2010 12:44:46 EST]]></pubDate>
<description><![CDATA[Orexigen Therapeutics has received federal support for its weight loss drug Contrave.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[The Skinny on Diet Pills]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/4452317/the-skinny-on-diet-pills/?]]></link>
<guid>http://video.foxbusiness.com/v/4452317/the-skinny-on-diet-pills/</guid>
<pubDate><![CDATA[Wed, 08 Dec 2010 12:08:06 EST]]></pubDate>
<description><![CDATA[FOXNewshealth.com Managing Editor Dr. Manny Alvarez on the new diet pill Contrave, backed by the FDA.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/120810/640/360/120810_fb_manny_FBN_120810_11-49.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Orexigen and Takeda Partner to Commercialize Obesity Treatment]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/09/02/orexigen-takeda-partner-commercialize-obesity-treatment/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/09/02/orexigen-takeda-partner-commercialize-obesity-treatment/</guid>
<pubDate><![CDATA[Thu, 02 Sep 2010 11:07:24 EDT]]></pubDate>
<description><![CDATA[Orexigen Therapeutics swung into the green Thursday morning after its announcement that it has entered into a partnership with Japan’s Takeda Pharmaceutical to commercialize a drug used to treat obesity.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Back-to-School Hits the Road]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/4298734/back-to-school-hits-the-road/?]]></link>
<guid>http://video.foxbusiness.com/v/4298734/back-to-school-hits-the-road/</guid>
<pubDate><![CDATA[Fri, 30 Jul 2010 15:09:41 EDT]]></pubDate>
<description><![CDATA[We break down what consumers are expecting from back-to-school sales, and what will keep you going the rest of the summer.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/073010/640/360/073010_fbl_fullshow_FBN_073010_13-21.jpg</media:thumbnail>
</item>
</channel>
</rss>
